Specific in situ immuno-imaging of pulmonary-resident memory lymphocytes in human lungs.

Autor: Humphries DC; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.; Research & Development, Sanofi, Marcy L'Etoile, France., O'Connor RA; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Stewart HL; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Quinn TM; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Gaughan EE; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Mills B; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Williams GOS; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Stone JM; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.; Centre for Photonic and Physics, Bath University, Bath, United Kingdom., Finlayson K; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Chabaud-Riou M; Research & Development, Sanofi, Marcy L'Etoile, France., Boudet F; Research & Development, Sanofi, Marcy L'Etoile, France., Dhaliwal K; Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom., Pavot V; Research & Development, Sanofi, Marcy L'Etoile, France.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 10; Vol. 14, pp. 1100161. Date of Electronic Publication: 2023 Feb 10 (Print Publication: 2023).

Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics.

Autor: Quinn TM; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Gaughan EE; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Bruce A; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Antonelli J; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., O'Connor R; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Li F; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., McNamara S; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Koch O; Regional Infectious Disease Unit, NHS Lothian, UK., MacKintosh C; Regional Infectious Disease Unit, NHS Lothian, UK., Dockrell D; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Regional Infectious Disease Unit, NHS Lothian, UK., Walsh T; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Blyth KG; Institute of Cancer Sciences, University of Glasgow, UK., Church C; Department of Respiratory Medicine, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board, Glasgow, UK., Schwarze J; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Boz C; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Valanciute A; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Burgess M; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Emanuel P; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Mills B; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Rinaldi G; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Hardisty G; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Mills R; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Findlay EG; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Jabbal S; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Duncan A; Regional Infectious Disease Unit, NHS Lothian, UK., Plant S; Regional Infectious Disease Unit, NHS Lothian, UK., Marshall ADL; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Young I; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Russell K; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Scholefield E; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Nimmo AF; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Nazarov IB; Latus Therapeutics, Oxford, UK; Department of Pharmacology, University of Oxford, Oxford, UK., Churchill GC; Department of Pharmacology, University of Oxford, Oxford, UK., McCullagh JSO; Department of Chemistry, University of Oxford, Oxford, UK., Ebrahimi KH; Institute of Pharmaceutical Science, King's College London, UK., Ferrett C; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Templeton K; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Rannard S; Centre of Excellence for Long-acting Therapeutics, Materials Innovation Factory and Department of Pharmacology and Therapeutics, University of Liverpool, UK., Owen A; Centre of Excellence for Long-acting Therapeutics, Materials Innovation Factory and Department of Pharmacology and Therapeutics, University of Liverpool, UK., Moore A; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Finlayson K; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Shankar-Hari M; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK., Norrie J; Centre for Cardiovascular Science, Queen's Medical Research Institute, Bioquarter, University of Edinburgh, Edinburgh, UK., Parker RA; Edinburgh Clinical Trials Unit (ECTU), Usher Institute, University of Edinburgh, Edinburgh, UK., Akram AR; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Anthony DC; Department of Pharmacology, University of Oxford, Oxford, UK., Dear JW; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh,; Centre for Cardiovascular Science, Queen's Medical Research Institute, Bioquarter, University of Edinburgh, Edinburgh, UK., Hirani N; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh., Dhaliwal K; Centre for Inflammation Research, Queen's Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK; Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh,. Electronic address: Kev.Dhaliwal@ed.ac.uk.

Publikováno v: EBioMedicine [EBioMedicine] 2022 Feb; Vol. 76, pp. 103856. Date of Electronic Publication: 2022 Feb 11.

Effect of galectin-3, IL-1, IL-6 and TNF-alpha on disease prognosis and mortality in COVID-19 patients.

Autor: Sancıoğlu Demir, Merve¹ sancioglumerve@gmail.com, Kuşcu, Ferit¹, Kurtaran, Behice¹, Candevir, Aslıhan¹, İnal, Ayse Seza¹, Kömür, Süheyla¹, Taşova, Yeşim¹

Publikováno v: Journal of Infection in Developing Countries. 2024 Supplement, Vol. 18, pS33-S39. 7p.

Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials.

Autor: Davidson, Mauricia¹ (AUTHOR) mauricia.davidson@gmail.com, Evrenoglou, Theodoros¹ (AUTHOR), Graña, Carolina^1,2,3 (AUTHOR), Chaimani, Anna^1,3 (AUTHOR), Boutron, Isabelle^1,2,3 (AUTHOR)

Publikováno v: BMC Medical Research Methodology. 1/11/2024, Vol. 24 Issue 1, p1-8. 8p.

Drug repurposing against SARS-CoV-2: A review based on principal reports.

Autor: Contreras-Puentes, Neyder¹ neyder.contreras@curnvirtual.edu.co, Conde-Cardona, Giancarlos² gian.conde@curnvirtual.edu.co, Gutierrez-Tovar, Brandon³ bgutierrezt10@curnvirtual.edu.co, Polo Martínez, Michelle³ mpolom10@curnvirtual.edu.co

Publikováno v: Archivos Venezolanos de Farmacología y Terapéutica. 2022, Vol. 41 Issue 9, p635-646. 12p.